Porton Advanced

Porton Advanced is a leading CDMO specializing in cell, gene and nucleic acid therapies, offering comprehensive GMP CMC manufacturing services for Investigator-Initiated Trials (IIT), IND submissions, as well as Phase I/II, Phase III, BLA, and commercial-scale production.

Our comprehensive service offerings include high-quality CRO (research-grade) and CDMO (GMP-like, GMP-grade) capabilities, encompassing IVT mRNA, LNP, circRNA, Vector Cloning, Plasmid, Lentivirus Packaging, Adeno-associated virus packaging, Gene editing (CRISPR-Cas), Stable cell lines engineering, and Cell Therapy CMC manufacturing and solutions.

Porton Advanced has extensive CMC experience and has completed 18 IIT projects and acquired 17 IND approvals with 300+ successful runs. Additionally, we have 5 ongoing Phase I/II projects.

Porton Advanced has recently launched a full-service Investigator-Initiated Trial (IIT) platform in collaboration with leading CRO partners (https://portonadvanced.com/platforms/investigator-initiated-clinical-trial-services/) enabling us to leverage our resources and networks effectively to accelerate your projects/clinical trials.